Régis T Costello
Costello, Régis
Costello, Régis T.
VIAF ID: 49437728 (Personal)
Permalink: http://viaf.org/viaf/49437728
Preferred Forms
- 200 _ | ‡a Costello ‡b Régis T.
- 100 1 _ ‡a Costello, Regis T.
- 100 1 _ ‡a Costello, Regis T.
- 100 1 _ ‡a Costello, Régis
-
- 100 0 _ ‡a Régis T Costello
4xx's: Alternate Name Forms (4)
Works
Title | Sources |
---|---|
Acute myeloid leukaemia triggering via CD40 induces leukocyte chemoattraction and cytotoxicity against allogenic or autologous leukemic targets | |
Agranulocytosis occurring in a patient with chronic lymphocytic leukemia in complete remission; treatment by rituximab and cyclosporin. | |
Analyse des sous populations lymphocytaires, et plus particulièrement les cellules NK, dans la polyglobulie primitive | |
[Androgens and haematopoiesis] | |
Approches thérapeutiques métaboliques et immunologiques des leucémies aiguës myéloïdes | |
Askin tumor and acute myeloid leukemia in a patient with constitutional partial Y disomy | |
[Breast plasmacytoma. 2 new cases] | |
Caractérisation des cellules natural killer dans la polyglobulie de Vaquez et dans la leucémie aigüe myéloïde | |
The CD2 and CD28 adhesion molecules induce long-term autocrine proliferation of CD4+ T cells | |
Characterization of Natural Killer Cells in Polycythemia Vera and in Acute Myeloid Leukemia. | |
[Chronic myeloid leukemia, biological aspects] | |
The co-expression of 2B4 (CD244) and CD160 delineates a subpopulation of human CD8+ T cells with a potent CD160-mediated cytolytic effector function | |
Deficient expression of NCR in NK cells from acute myeloid leukemia: Evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction. | |
Differential immuno-suppressive effects of metabolic inhibitors on T-lymphocyte activation. | |
[Eosinophils and antitumour response] | |
Functional defects and molecular mechanisms of Left Ventricular Noncompaction (LVNC) in Nkx2.5 mutant mice | |
Granular lymphoproliferative disorder, autologous blood stem cell transplantation and multiple myeloma | |
Hematological reconstitution and gene therapy: retroviral transfer of the bacterial beta-galactosidase activity into human hematopoietic CD34+ cell populations and into T lymphocytes derived from the peripheral blood. | |
[Hodgkin's disease in patients infected with the human immunodeficiency virus] | |
[Horton's disease and chronic lymphoid leukemia] | |
How to restore normal innate antitumor immunity in acute leukemia? | |
Human CD28 and CTLA-4 Ig superfamily genes are located on chromosome 2 at bands q33-q34. | |
[IgAk solitary bone plasmacytoma leading to the loss of heavy chain alpha] | |
Immune deficiency and cancer | |
The immunophenotype of minimally differentiated acute myeloid leukemia (AML-M0): reduced immunogenicity and high frequency of CD34+/CD38- leukemic progenitors. | |
Immunoregulatory cells and effector cells in polycythemia vera. | |
Impaired activating receptor expression pattern in natural killer cells from patients with multiple myeloma | |
Intensive chemotherapy with rituximab is safe and effective in AIDS non-Hodgkin's lymphoma | |
Is R-CHOP Therapy a Lymphoma Growth Factor? | |
LIGHT, a new TNF superfamily member, is essential for memory T helper cell-mediated activation of dendritic cells. | |
LIGHT costimulates CD40 triggering and induces immunoglobulin secretion; a novel key partner in T cell-dependent B cell terminal differentiation. | |
L'utilisation de cellules natural killer (NK) comme outil thérapeutique : étude clinique de phase 1 de perfusion de cellules NK du donneur après HSCT : Annexe : Pumilio 2, une protéine de liaison à l'ARN surexprimée dans les cellules NK de patients atteints de LAM, réprime les fonctions des cellules NK | |
[Mechanisms of tumor escape from immunologic response]. | |
MELISSE, a large multicentric observational study to determine risk factors of venous thromboembolism in patients with multiple myeloma treated with immunomodulatory drugs. | |
Minor breakpoint cluster region (m-BCR) positive chronic myeloid leukaemia with an acute lymphoblastic leukaemia onset: a case report | |
Multifactorial hypokalaemia in a beer drinker | |
[Native valve Staphylococcus lugdunensis endocarditis in a patient with lymphoma] | |
Natural killer cells and immunity against cancer | |
[Necrotic myocarditis in acute eosinophilic lymphoblastic leukaemia] | |
[New insights into cytotoxic effector cells] | |
Pretransplantation blood transfusion | |
Primary plasma cell leukaemia: a report of 18 cases | |
Proliférations réactionnelles à grands lymphocytes granuleux | |
Pronostic factors of Hodgkin lymphomas : influence of the microenvironment. | |
Pseudo-"acid retinoic syndrome" mimicked by severe influenza A infection | |
[Pulmonary arterial hypertension and malignant hematologic disorders] | |
Pulmonary hypertension in patients with chronic myeloproliferative neoplasms | |
Rank ligand stimulation induces a partial but functional maturation of human monocyte-derived dendritic cells. | |
Rapid evolution of multiple myeloma after cobalamin therapy for megaloblastic erythropoiesis with macrocytic anemia | |
Récepteurs activateurs des cellules Natural Killer humaines dans les hémopathies malignes = uman Natural Killer cells triggering receptors in haematological malignancies | |
Recurrent hepatic hematoma due to familial lysozyme amyloidosis resolves with conservative management | |
Recurrent superior vena cava syndrome caused by IgD multiple myeloma. | |
Redox modulation and hematological malignancies : from preclinical study of an aldehyde dehydrogenase inhibitor to phase I trial. | |
Reversing the multidrug resistance in acute leukemia: until the leukemia initiating cell? | |
A role for HVEM, but not lymphotoxin-beta receptor, in LIGHT-induced tumor cell death and chemokine production | |
Role of high-dose therapy and initial response in survival of poor-risk patients with aggressive non-Hodgkin's lymphoma: a retrospective series on 126 patients from a single center | |
[Severe hypokalemia with few symptoms disclosing distal renal tubular acidosis] | |
Stimulation of non-Hodgkin's lymphoma via HVEM: an alternate and safe way to increase Fas-induced apoptosis and improve tumor immunogenicity | |
Surface expression and function of p75/AIRM-1 or CD33 in acute myeloid leukemias: engagement of CD33 induces apoptosis of leukemic cells | |
T-lymphocyte activation via monoclonal antibodies directed against CD2 and CD28 molecules. | |
Therapeutic use of granulocyte-macrophage colony-stimulating factor (GM-CSF). A review of recent experience. | |
Third case of acute monocytic leukemia (M5) occurring in an HIV-seropositive man: a case report | |
Transcriptomic approach contribution in the physiopathology and treatment of hematological malignancies. | |
Translocation of BCR to chromosome 9 in a Philadelphia-negative chronic myeloid leukemia | |
Treatment of essential thrombocythemia | |
Unbalanced translocation t(5;17) in an typical acute promyelocytic leukemia | |
Use of epoetin : analysis of practice in general hospital complex in 2004. | |
Use of natural killer cells (NK) as a therapeutic tool : phase I clinical study of NK donor lymphocyte infusion after HSCT : Annex : Pumilio 2, a RNA binding protein upregulated in NK cells from AML patients, represses functions of NK cells. | |
Utilisation de l'EPO [Erythropoïétine] : analyse des pratiques en centre hospitalier général en 2004 | |
[Value of intravenous gamma globulins at heavy dose in thrombopenia in a case of leptospirosis] | |
VIH-Sida et cancers les affections malignes au cours de l'infection par le VIH | |
What is the real role of CD40 in cancer immunotherapy? |